Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - A Randomized Clinical Trial in Acute Kidney Injury

Recruiting

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(33 sites)

United States

University of Alabama Birmingham Hospital, Birmingham, Alabama

Central Arkansas Veterans Healthcare, Little Rock, Arkansas

Ronald Reagan UCLA Medical Center, Los Angeles, California

Stanford University, Palo Alto, California

University of Colorado Hospital Anschutz Medical Campus, Aurora, Colorado

AdventHealth Orlando, Orlando, Florida

Orlando Regional Medical Center, Orlando, Florida

JMS Burn Center, Augusta, Georgia

University of Iowa Hospital, Iowa City, Iowa

University of Kentucky HealthCare, Lexington, Kentucky

Ochsner LSU Health Academic Medical Center, Shreveport, Louisiana

University of Michigan, Ann Arbor, Michigan

Henry Ford Medical Center, Detroit, Michigan

Mayo Clinic, Rochester, Minnesota

UNLV Health, Las Vegas, Nevada

Unversity of Rochester, Rochester, New York

University of North Carolina, Chapel Hill, North Carolina

University of Cincinnati, Cincinnati, Ohio

Cleveland Clinic, Cleveland, Ohio

Samaritan Health, Corvallis, Oregon

St Luke's University Hospital, Bethlehem, Pennsylvania

Saint Mary Medical Center, Langhorne, Pennsylvania

Nazareth Hospital, Philadelphia, Pennsylvania

Geisinger Wyoming Valley Medical Center, Wilkes-Barre, Pennsylvania

Medical University of South Carolina, Charleston, South Carolina

University of Texas Southwestern Medical Center, Dallas, Texas

Brooke Army Medical Center, Fort Sam Houston, Texas

United States Army Institute of Surgical Research, JBSA Fort Sam Houston, Texas

Methodist Hospital Metropolitan, San Antonio, Texas

Methodist Hospital, San Antonio, Texas

University of Texas Health San Antonio, San Antonio, Texas

Sentara Health, Norfolk, Virginia

Virginia Commonwealth University, Richmond, Virginia